The center in Chochabamba is a subsidiary of the Global Stem Cells Group and is the 35th such center in the world.

MIAMI LAKES, Florida—The Global Stem Cells Group, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is pleased to announce the opening of the Stem Cells Center in Chochabamba, Bolivia. Inaugural events celebrating the center’s opening will take place in Chochabamba on June 8-9, 2019.

The Bolivian center is the 35th Stem Cells Center in the world, strengthening the Global Stem Cells Group’s presence worldwide as they seek to expand research for and the practice of regenerative medicine across the globe.

Representatives from the Global Stem Cells Group and local physicians alike see the impending impact on the Bolivian medical community from having an innovative center such as the Stem Cells Center as a positive one. The center will offer a permanent space within the country where industry experts can train Bolivian doctors in the latest stem cell therapies. These training programs will result in better care for Bolivian patients suffering from degenerative conditions by keeping care close to home and introducing them to more effective treatment options.  

The Global Stem Cells Group will provide the center with all necessary medical equipment to support a regenerative medicine practice. The group additionally provided training to all Bolivian doctors and support staff working at the center, which will be led by Dra. Cecilia Vargas.

As part of the two-day inaugural celebration, Global will be hosting a social at the Hotel Chochabamba on June 8th. The local medical community is welcome to join the event.

To learn more about the Global Stem Cells Group, visit http://www.stemcellsgroup.com/.

To learn more about the Stem Cells Center, visit  https://www.youtube.com/watch?v=Q4ubnCSVpSs

ISSCA doctors to serve as keynote speakers at international conference and will host an additional stem cells course in Barcelona.

MIAMI LAKES, Florida— The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has accepted an invitation to speak at the XXVIIas Jornadas Mediterraneas de Confrontaciones Terapeuticas en Medicina y Cirugia Cosmetica in Barcelona. The conference will be held on May 23-25, 2019 at the Hotel Barceló Sants, with experts from ISSCA leading the keynote session on May 25th. Following the conference on May 26th,, ISCCA doctors will also be hosting a one-day stem cells course for practitioners of regenerative medicine.

Dra. Maritza Novas of the United States and Dr. Leopoldo Parada of Chile will be speaking on behalf of ISSCA about new therapies based on allogenic compounds such as amniotic liquid, Wharton’s jelly, cord blood, and exosomes and how they present exciting new treatment opportunities for those practicing regenerative medicine.

Drs. Novas and Parada will shed light on new advances in allogenic compound research and share details with regenerative medicine practitioners on how allogenic compounds are safe treatment options for their patients, as they must pass through rigorous quality control in labs before being shipped to medical offices. Additionally, independent tests show that allogenic compounds have better cellular counts than other biological matter. Doctors currently using allogenic compounds have also reported faster treatment times associated with allogenic protocols, citing a 15-minute turnaround time versus 2 hours required to obtain stem cells from their patients.

After completing their keynote talk at Jornadas Mediterraneas, Drs. Nova and Parada will be leading a one-day stem cells seminar to discuss in further detail allogenic compound clinical applications and the latest clinical trials. The seminar will wrap up with a live patient demonstration.

ISSCA has attended Jornadas Mediterraneas for the last six years. It is a premier conference in the medical community attracting more than 500 doctors from across the globe each year.

To learn more about ISSCA and all of their upcoming and past events, visit https://issca.us/.

ISSCA’s training programs assist physicians and researchers in developing better protocols for stem cell treatments.

MIAMI LAKES, Florida— The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is continuing to expand its global training efforts by sponsoring three upcoming training sessions over the next month. The group has a busy schedule, with trainings taking place in Amsterdam, Abu Dhabi, Atlanta, Bogota, Miami and Mexico City.

ISSCA instructors will be hosting two onsite trainings, one in Amsterdam, Netherlands on February 22-23 and another in Abu Dhabi, United Arab Emirates on March 2-3. The training is designed to assist physicians interested in introducing regenerative medicine into their practices adhere to industry practices. Physicians will learn about industry developments and the latest advances in cellular-based treatment protocols.

Utilizing ISSCA’s over 10 years of experience in regenerative medicine, the onsite trainings seek to bring the latest advances in the field to physicians across the world, removing barriers to access. In addition to training physicians, the group uses hands-on-training methods to instruct other medical staff in cellular treatment protocols so they can effectively assist their tending physicians. Trainings are highly personalized and offer physicians the ability to learn only the regenerative medicine treatments they are most interested in.

In early March, ISSCA instructors will also be traveling to Atlanta, Georgia to train physicians on allogenic compound stem cells derived from cord blood. This two-day training will take place in on March 29-30. Physicians with an interest in new regenerative medicine breakthroughs that have produced safer and shorter recovery times and those that have led to higher cellular counts in the degenerative disease treatment process will find this training of interest.

Instructors will lead physicians through a deep dive into the latest stem cell advances pertaining to cord blood research. Attendees will learn about processes for how to extract stem cells from a healthy donor and protocols on how to process stem cells in the lab while adhering to the highest quality control standards.

Instructors will additionally share the science behind allogenic compounds derived from cord blood and which current protocols use cord blood derived stem cells to promote patient healing.

ISSCA trainers will be rounding out their upcoming training schedule with visits to Bogota, Colombia on March 15-16, Miami, Florida on March 22-23 and Mexico City, Mexico on March 29-30. These three trainings will offer Stem Cell Training Certification for physicians seeking to expand their knowledge on the newest stem cells protocols for those wanting to integrate regenerative medicine into their practices. The protocols covered in the trainings can be implemented in medical offices with mini lab equipment. The instructors will engage physicians in hands-on instruction where doctors can practice on live patients.

Trainings in Bogota and Mexico City will be conducted in Spanish, and interested participants can find more information at www.cursocelulasmadre.com, while interested Miami participants can learn more at https://www.stemcelltraining.net/hands-on-course.

To learn more about ISSCA, visit https://www.issca.us/

ISSCA to host upcoming regenerative medicine conference in Miami that provides training on allogeneic cellular-based products

MIAMI LAKES, Florida—The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is set to host a conference in Miami on October 25-26, 2019.

The conference will be held at the Biltmore Hotel and will offer more than 250 attendees the opportunity to learn more about allogenic cellular-based products and how they play a critical role in the future of regenerative medicine.

 

Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols and advances are encouraged to attend the Miami conference. In this two-day event, attendees will learn why allogeneic cellular-based products have become today’s most popular regenerative medicine therapeutic option.

Well-respected scientists and researchers in the field of regenerative medicine from across the globe world will share with the audience the basic concepts needed to determine which allogenic cellular-based products are safe to use and what type of clinical indications can be targeted effectively.

“We are pleased to bring this informative and exciting conference to Miami,” said Benito Novas Global Stem Cells Group Founder and CEO. “Our goal is to give doctors the knowledge they need to begin implementing cellular-based treatments in their own practices. These types of treatments have been proven effective in a host of clinical scenarios, including speeding up the patient’s rate of recovery and pain management.”

To learn more about ISSCA, visit https://www.issca.us/

ISSCA’s training assists hospital in developing better protocols for gynecological treatments.

MIAMI LAKES, Florida—The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, traveled to Guadalajara, Mexico in early February to collaborate with area physicians on how to utilize advancements in stem cell research and technology to find new solutions to health issues and concerns.

During ISSCA’s visit to Hospital Angeles del Carmen, physicians with the group partnered with Dr. Norma Patricia Ramos, director of the hospital’s gynecological department. During the two-day visit, ISSCA’s researchers and physicians provided valuable training and guidance on how stem cells can be used to develop better protocols for treating vaginal stenosis.

Vaginal stenosis is a condition that causes narrowing and/or loss of flexibility of the vagina and is a side effect of radiotherapy and/or genital surgery. It is often also accompanied by dryness and loss of resiliency of scar tissue.

The group reviewed new and effective treatment protocols available through stem cell therapies, including combining traditional CO2 laser treatments with stem cells harvested from adipose tissue.

The group also worked with Dr. Ramos and her team on new stem cell protocols to help women who have tried in vitro fertilization to get pregnant but have not experienced success due to a lack of ovarian reserves. The ISSCA group shared new research on the viability of utilizing stem cells from adipose tissue or bone marrow and reintegrating it into the ovaries using a laparoscopy with the goal of increasing ovarian reserves and increasing chances of pregnancy. Poor ovarian reserve (POR) is critical limiting factor for the success of any treatment modality for infertility, and new stem cell treatments provide a promising treatment protocol in increasing the quantity and quality of oocytes in women of reproductive age.

ISSCA is committed to partnering with physicians and researchers worldwide who have a vested interest in finding new solutions to improve treatments for any conditions. The group has an upcoming trip to Buenos Aires to partner with orthopedic doctors to discuss opportunities for stem cell therapies to improve treatment protocols in the field of orthopedics.

To learn more about ISSCA, visit https://www.issca.us/.

About ISSCA:

The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine.  Their code of ethics emphasizes principles of morals and ethical conducts.

At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative

medicine and make it available to benefit patients both nationally and globally.

For more information, please visit https://www.issca.us/ or send an email to info@stemcellsgroup.com

cell therapy fellowship

 

 

 

 

 

 

 

ISSCA’s 2019 “Applications of Cell Therapies in Medicine and Aesthetic Surgery” symposium agenda to focus on allogeneic compounds in the regenerative medicine industry.

MIAMI, Dec. 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host its sixth annual “Applications of Cell Therapies in Medicine and Aesthetic Surgery” regenerative medicine symposium in Buenos Aires, Argentina August 16-17, 2019. The focus of the symposium agenda will be allogeneic compounds—how they have changed the regenerative medicine industry, and how the industry will accommodate the challenges allogeneic therapies present.

The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research.

In 2018, the  5th annual symposium was held in three international cities—Buenos Aires, Istanbul, Turkey and Caracas, Venezuela. Each event exceeded organizers’ expectations both in attendance numbers and active participation. More than 200 physicians from the U.S., South America, Europe, the Middle East and Asia  attended the symposiums in Istanbul and Caracas, and more than 350 physicians from around the world attended in Buenos Aires.

 The high attendance and enthusiastic participation of attendees at the Argentina symposium, which was held at the Universidad de Buenos Aires, compelled ISSCA organizers to reconsider their multi-country strategy and host the event exclusively in  Buenos Aires in 2019. In addition, ISSCA has committed to hosting the annual symposium in Buenos Aires for the next six consecutive years.

In keeping with ISSCA’s commitment to supporting the most current advances in stem cell and regenerative medicine discoveries, the 2019 symposium will explore  the impact the acceleration of allogeneic compounds have had on the industry, new challenges they bring to the market, and promising new therapies they are expected to provide to an ever-widening spectrum of diseases and medical conditions.

A group of renowned international speakers, experts in the field of stem cell and regenerative medicine including the latest advances in allogeneic therapies, will lead rigorous scientific discussions and Q&A sessions with physicians in attendance. In Addition, ISSCA has invited representatives from  [name of’ lab?], one of the world’s largest regenerative medicine labs to share their experiences and knowledge with physicians representing the global medical community in attendance,

The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells and regenerative medicine solutions.. In addition, business opportunities, industry challenges, and potential strategies for overcoming those challenges will be discussed.

The event venue in Buenos Aires will be announced shortly.

To learn more about the ISSCA Buenos Aires symposium and to reserve a seat, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Regenerative medicine symposium allogeneic compounds

American Association of Stem Cell Physicians summit

American Association of Stem Cell Physicians summitISSCA has released its 2019 regenerative medicine training calendar for physicians, to be held in seven international cities.  

MIAMI,  Dec. 4, 2018—The International Society for Stem Cell Application (ISSCA) has released its 2019 regenerative medicine certification training course calendar, with programs scheduled in seven international cities and updated curriculum. ISSCA’s objective in 2019 is to provide enhanced educational qualifications to physicians looking for a new approach to treat patients suffering with chronic pain, severe injury, and degenerative conditions and diseases.

The two-day regenerative medicine training course, which teaches easy-to-follow protocols for harvesting adipose and bone marrow stem cells from patients in a clinical environment, will also feature new treatment basics involving allogeneic compounds including exosomes and  other compounds derived from (umbilical) cord blood and amniotic fluid, allowing participating physicians to easily and efficiently add certification in cutting-edge regenerative medicine therapies to their practices.

Participating physicians learn how to harvest and isolate bone marrow and adipose-derived autologous stem cells to use in treating multiple conditions.

The two-day course begins with a four-hour lecture on advances in regenerative medicine. Participating physicians will receive more than 12 hours of hands-on training with live patients in protocols for obtaining stem cells from patients, applications that they can take back to their medical offices or clinics and begin using immediately.  

Attendees will also receive 12 protocols in digital format to take with them, and gain knowledge and practical skills to easily add regenerative medicine therapies to their practices.

Physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets and more.

The 2019 ISSCA training course calendar is as follows:

January 18-19, 2019  Miami, Fla. (conducted in Spanish language).

http://cursocelulasmadre.com/entrenamiento-miami-mail/ January 25.26, 2019  Miami, Fla. (Conducted in English language). https://www.stemcelltraining.net/miami-stem-cells-course-adwords/

 

February 1-2, 2019  Quito, Ecuador

http://cursocelulasmadre.com/entrenamiento-quito-mail/

February 8-9, 2019  Buenos Aires, Argentina

https://cursocelulasmadre.com/entrenamiento-argentina-mail/

February 15-16, 2019, Lima, Peru

http://cursocelulasmadre.com/entrenamiento-lima-mail/

Fenruary 22-23, 2019  Bogota, Colombia

http://cursocelulasmadre.com/entrenamiento-bogota-mail/

March 1-2, 2019  Mexico City, Mexico

https://cursocelulasmadre.com/entrenamiento-cancun-mail/ – needs to be fixed – links to a December date!

March 8-9  Abu Dabhi, UAE  

https://www.stemcelltraining.net  – not a good link! Please correct

ISSA’s stem cell certification course offers practical, personalized training in stem cell harvesting and isolation procedures. To date, ISSCA has trained more than 2,000 physicians worldwide.

Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.

To learn more about the ISSCA certification training courses and to register to participate, visit the Stem Cells Training website, the email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.   

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

                                                                     ###
ISSCA 2019 certification training calendar

ISSCA Barcelona Symposium

Global Stem Cells Group founder and CEO Benito Novas was honored for his leadership in regenerative medicine at the  III International Medical Scientific Congress and Business Development Nov. 24, 2018 in Cartagena, Colombia.

MIAMI, Dec. 4, 2018–Global Stem Cells Group founder and CEO Benito Novas received Accredited Member status and International leadership award from  Cartagena University and International Society in Research, Health, Business Development and Technology at the  III International Medical Scientific and Business Development Congress Nov. 24, 2018 at Cartagena University in Colombia.

Novas received recognition as a  high-scale marketer with proven leadership in the management of operations in the health sector as head of Global Stem Cells Group, a U.S.-based group of regenerative medicine companies with a permanent presence in 26 countries that includes training and business operations in the areas of ​​cell therapies and tissue engineering.

Novas is also director of public relations for the (International Society for Stem Cell Applications (ISSCA) and founder of Estetica Marketing, a comprehensive advertising agency for the aesthetic medicine sector that provides more than 15 years’ experience instructing health sector professionals in successful business development practices.

The award acknowledges Novas’s contributions in providing high-quality education to physicians around the world looking to  add regenerative medicine therapies to their practices. It also acknowledges Novas’s work as a strategist, passionate digital marketing consultant and author of the books “Your Aesthetic Practice:  A Complete Guide: What Your Patients are Saying” and “Digital Marketing in the Aesthetic Clinic.”

A global entrepreneur, manager, and keynote speaker with expertise in the field of specialized marketing focused on biotechnology, life sciences, and healthcare development, Novas is driven by the desire  to maintain a perpetual flow of knowledge and innovation regarding the role of stem cells in modern medicine. His goal is to

accelerate the process of making stem cell research, technology and therapies readily available to benefit the health and well-being of a broad range of patients worldwide.

To learn more about Benito Novas and Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world. About Adimarket: Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.

                                                                     ###

Regenerative medicine Vlog

Caracas Venezuela stem cell training

 

 

 

 

 

 

 


ISSCA will conduct a hands-on regenerative medicine certification training course for physicians  in Caracas, Venezuela Dec. 2-3, 2018. Global Stem Cells Group will sponsor 50 percent of the training fees to provide most physicians in economically-strapped Venezuela with access to regenerative medicine education.

MIAMI, Nov. 1, 2018—The International Society for Stem Cell Application (ISSCA) announces plans to hold a regenerative medicine certification training course in Caracas, Venezuela  Dec. 2-3, 2018. The two-day course teaches easy-to-follow protocols for harvesting adipose and bone marrow stem cells from patients in a clinical environment..

The training program follows the organization’s sponsored regenerative medicine symposium in Caracas on Dec. 1, 2018.  ISSCA affiliate  Global Stem Cells Group Group is sponsoring the training program and funding 50 percent of  fee costs to ensure most Venezuelan physicians can attend.

GSCG CEO and ISSCA Vice President Benito Novas says the training program is an important part of the organizations’ commitment to spreading knowledge and physician training in regenerative medicine to medical professionals worldwide. This commitment includes strategies to accommodate countries like Venezuela that lack the resources to train physicians to implement regenerative medicine procedures in clinical settings.

“Our  goal is to make economically and therapeutically viable regenerative medicine therapies available to Venezuelans by training and educating physicians throughout the country in stem cell therapies and protocols they can provide to patients in their clinics, says Novas. “We’re driven by our conviction that stem cell medicine will bring transformative changes to the healthcare industry at a global level.

Participating physicians learn how to harvest and isolate bone marrow and adipose-derived autologous stem cells  to use in treating multiple conditions.

The two-day course begins with a four hour lecture on advances in regenerative medicine. Participating physicians will receive more than 12 hours of hands-on training with live patients  in protocols for obtaining stem cells from patients that can be used in the medical office. They will also receive 12 protocols in digital format to take back to their practices and begin using stem cell applications immediately.

The course provides participating physicians with training in stem cell therapies to treat a variety of conditions. Participating physicians gain Knowledge and practical skills to easily add regenerative medicine to their practices.

Physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets and more.

ISSCA’s stem cell certification course offers practical, personalized training in stem cell harvesting and isolation..ISSCA has trained more than 2,000 physicians worldwide.

Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.

To learn more about the ISSCA certification training course and to register to participate, visit the Stem Cells Training website, the email info@stemcellsgroup.com, or call 305-560-5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.                  

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Global Stem Cells Group:
programmed stem cellsGlobal Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world. About Adimarket: Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.

                                                                      ###

Caracas Venezuela stem cell training

 

 Holya Aziza El Materi Ep Khemiri, M.D. named Vice President Business Development Africa and Europe.

Holya Aziza El Materi Ep Khemiri, M.D.

 

 

 

 

 

 

Global Stem Cells Group announces the appointment of Holya Aziza El Materi Ep Khemiri, M.D. as Vice President Business Development Africa and Europe. Khemiri will oversee development of a new Stem Cell Center in Tunisia.

MIAMI, Nov. 1, 2018—Global Stem Cells Group founder and CEO Benito Novas has named Holya Aziza El Materi Ep Khemiri, M.D. Vice President Business Development for Africa and Europe. The announcement is the latest update on the regenerative medicine organization’s expansion of its clinical presence on the two continents.

Khemiri, who specializes in pharmaceutical and parapharmacy medicines, product manufacturing and medical industry business development, will be in charge of developing and opening a new Stem Cell Center in Tunisia focused on the treatment of patients with degenerative illnesses and orthopedic impairments, and professional athletes with sports injuries.  

Stem Cell Center Tunisia will provide regenerative medicine training to African physicians who wish to offer stem cell therapies in their practices.

Since opening the first African Stem Cell Center in Casablanca, Morocco in July, 2017, GSCG has accelerated  momentum to bring regenerative medicine, training and education to Africa and Europe through expanded networking opportunities introducing the organization’s authoritative training programs, workshops, seminars, online marketplace for  regenerative medicine products, expert instruction and advice on marketing for regenerative practices and other innovative initiatives.

Stem Cell Center Tunisia is part of Global Stem Cells Group’s strategy to facilitate  international growth and bring quality-of-life-enhancing  regenerative medicine to patients in every corner of the world. The Tunisian center’s medical team will work closely with regional patients, educators and regulators to foster engagement and promote stem cell medicine technology.

ction as a regenerative medicine reference for physicians  in North Africa, providing physicians with instruction in stem cell therapies and protocols Those wishing to implement stem cell oversight in their practices will be able to visit the office and collaborate other physicians, participate in educational classes and workshops, and  receive the training necessary to start implementing regenerative medicine in their practices and clinics.

Additionally, Stem Cell Center Tunisia will  offer physicians a stem cell processing center, GSCG’s  complete solution for onsite  tissue processing, isolation, culturing and cryopreservation of stem cells. One of the biggest challenges of using traditional stem cell harvesting protocols  in medical office settings is obtaining enough stem cells to treat certain degenerative conditions such as autism, lupus. Parkinson’s Disease, Alzheimer’s Disease and others.

The stem cell processing center provides a solution that allows physicians to expand stem cell colonies and obtain a significantly larger number of cells sufficient to treat patients. It also  helps with patients needing multiple stem cell treatments by allowing the physician to perform a single extraction of stem cells from fat tissue; the cells harvested can then be saved and expanded, eliminating the need for new cell extraction with each treatment.

According to Novas, Khemiri’s skills and experience make her an ideal candidate to spearhead Stem Cell Center Tunisia’s development and opening.

“Dr. Khemiri brings an array of expertise and knowledge to our expansion efforts in Africa and Europe,” says Novas. She joins Global Stem Cells Group’s management team as a welcome addition at a time when our international expansion endeavors are growing exponentially.”

Khemiri was president of Tunisia’s Society Isotope Radioavtive (SISORA) from 2011 to 2014, where she was involved in manufacturing radioactive tracers to detect cancer. As president of the organization, she helped establish a partnership between SISORA and Belgium-based Radio Pharma Solultions (IBA).

From 2008 to 2011, she served as  Research and Development Director of ADWYA,  a Tunisia-based company specializing in the production of pharmaceutical products for medical and veterinary use and the country’s first private pharmaceutical laboratory and one of its largest private pharmaceutical companies.

In  2010, she served as creative director of  RAD where she focused on formula and scientific studies and registration of medicines, skin care and food supplements with the Tunisian Health Ministry.

Khemari received her medical training at the Catholic University of Louvain in Brussels, Belgium from 1999 to 2006. She received a diploma in Pharmaceutical Sciences from the the Institut Roger Lambion in Brussels and  a diploma in Biochemistry, Cosmetology, and Science Perfumery from the University Libre in Brussels.

For more information, visit the Global Stem Cells Group website,   email info@stemcellsgroup.com or call 305-560-5337.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world. About Adimarket: Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.

                                                                      ###

Holya Aziza El Materi Ep Khemiri named Vice President Business Development Africa and Europe.